I’m a bit skeptical about the hype around the new Injective ETF. Sure the headlines say it’s a big deal, but the token is only up 0.1% in the last 24 hrs and sits just above its 8‑hour swing support of $8.03. The ETF launch could bring some fresh institutional interest, but the market still looks sideways and the 13% rally is a one‑off that might not hold. Bottom line: $INJ is likely to stay near the $8.03–$8.45 zone for now – it’s not a breakout yet. DYOR.